Liver transplant risk score under the microscope

NCT ID NCT07570901

Completed Knowledge-focused Sponsor: University of Jena Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 446 liver transplant patients to see if changes in their MELD score (a measure of liver disease severity) could predict who might not survive. Researchers focused on patients with high MELD scores, who are at greater risk. The goal is to better understand how to prioritize and care for these patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors better identify which liver transplant patients are at highest risk, potentially improving how organs are allocated.
What could go wrong: This is an observational study, not a treatment trial. It looks at existing data, so it cannot prove cause and effect. Results may not change practice without further research.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END STAGE LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic liver failure liver disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LIVER DISEASE (ALCOHOLIC OR NOT) LIVER TRANSPLANTATION

Contacts and locations

Locations

Jena University Hospital

Jena, Thueringia, 07747, Germany
Toronto General Hospital

Toronto, Ontario, M5G 2C4, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.